Effects of Valsartan Alone Versus Valsartan/Simvastatin Combination on Ambulatory Blood Pressure, C-Reactive Protein, Lipoproteins, and Monocyte Chemoattractant Protein–1 in Patients With Hyperlipidemia and Hypertension
- 15 July 2007
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 100 (2) , 222-226
- https://doi.org/10.1016/j.amjcard.2007.02.085
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Endothelial Protection, AT 1 Blockade and Cholesterol-Dependent Oxidative StressCirculation, 2006
- Large Artery Stiffness and Antihypertensive AgentsCurrent Pharmaceutical Design, 2005
- Additive Beneficial Effects of Losartan Combined With Simvastatin in the Treatment of Hypercholesterolemic, Hypertensive PatientsCirculation, 2004
- Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With MicroinflammationCirculation, 2004
- Inflammation as a Cardiovascular Risk FactorCirculation, 2004
- High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary preventionThe American Journal of Cardiology, 2003
- Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertensionPublished by Elsevier ,2002
- Statins and blood pressure regulation.Current Hypertension Reports, 2001
- Effect of the HMG-CoA Reductase Inhibitors on Blood Pressure in Patients With Essential Hypertension and Primary HypercholesterolemiaHypertension, 1999